Literature DB >> 22515110

Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics.

Hiroshi Saito1, Akihiro Tomita, Haruhiko Ohashi, Hideaki Maeda, Hisao Hayashi, Tomoki Naoe.   

Abstract

We attempted to clarify the storage iron metabolism from the change in the serum ferritin level. We assumed that the nonlinear decrease in serum ferritin was caused by serum ferritin increase in iron mobilization. Under this assumption, we determined both ferritin and hemosiderin iron levels by computer-assisted simulation of the row of decreasing assay-dots of serum ferritin in 11 patients with normal iron stores free of both iron deficiency and iron overload; chronic hepatitis C (CHC) and iron deficiency anemia after treatment, and 11 patients with iron overload; hereditary hemochromatosis (HH) and transfusion-dependent anemias (TD). We determined the iron removal rates of 20 and 17 mg/day by administering mean doses of deferasirox at 631 and 616 mg/day in 2 TD during the period of balance of iron addition and removal as indicated by the serum ferritin returned to the previous level. The ferritin-per-hemosiderin ratio was almost the same in both HH and CHC. This matched the localized hepatic hemosiderin deposition in CHC with normal iron stores. We detected the ferritin increased by utilizing the hemosiderin iron in iron removal and the ferritin reduced by transforming ferritin into hemosiderin in iron additions. The iron storing capacity of hemosiderin was limitless, while that of ferritin was suppressed when ferritin iron exceeded around 5 grams. We confirmed the pathway of iron from hemosiderin to ferritin in iron mobilization, and that from ferritin to hemosiderin in iron deposition. Thus, serum ferritin kinetics enabled us to be the first to clinically clarify storage iron metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515110      PMCID: PMC4831249     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  30 in total

Review 1.  Ferritin in serum. Clinical and biochemical implications.

Authors:  A Jacobs; M Worwood
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

2.  Denaturation of ferritin and its relationship with hemosiderin.

Authors:  G T MATIOLI; R F BAKER
Journal:  J Ultrastruct Res       Date:  1963-06

3.  Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury.

Authors:  G Ambrosio; J L Zweier; W E Jacobus; M L Weisfeldt; J T Flaherty
Journal:  Circulation       Date:  1987-10       Impact factor: 29.690

4.  Iron metabolism; iron stores in man as measured by phlebotomy.

Authors:  D HASKINS; A R STEVENS; S FINCH; C A FINCH
Journal:  J Clin Invest       Date:  1952-06       Impact factor: 14.808

5.  A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Authors:  Maria Domenica Cappellini; Alan Cohen; Antonio Piga; Mohamed Bejaoui; Silverio Perrotta; Leyla Agaoglu; Yesim Aydinok; Antonis Kattamis; Yurdanur Kilinc; John Porter; Marcello Capra; Renzo Galanello; Slaheddine Fattoum; Guillermo Drelichman; Carmelo Magnano; Monica Verissimo; Miranda Athanassiou-Metaxa; Patricia Giardina; Alexandra Kourakli-Symeonidis; Gritta Janka-Schaub; Thomas Coates; Christiane Vermylen; Nancy Olivieri; Isabelle Thuret; Herbert Opitz; Catherine Ressayre-Djaffer; Peter Marks; Daniele Alberti
Journal:  Blood       Date:  2005-12-13       Impact factor: 22.113

6.  The cellular labile iron pool and intracellular ferritin in K562 cells.

Authors:  A M Konijn; H Glickstein; B Vaisman; E G Meyron-Holtz; I N Slotki; Z I Cabantchik
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

7.  Serum ferritin in patients with iron overload and with acute and chronic liver diseases.

Authors:  J Prieto; M Barry; S Sherlock
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

Review 8.  Idiopathic hemochromatosis, an interim report.

Authors:  M S Milder; J D Cook; S Stray; C A Finch
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

9.  Clinical aspects on total iron-binding capacity (TIBC), unsaturated iron-binding capacity (UIBC) and serum iron (SI).

Authors:  H Saito
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1978-12

10.  An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload.

Authors:  G M Addison; M R Beamish; C N Hales; M Hodgkins; A Jacobs; P Llewellin
Journal:  J Clin Pathol       Date:  1972-04       Impact factor: 3.411

View more
  5 in total

Review 1.  METABOLISM OF IRON STORES.

Authors:  Hiroshi Saito
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

2.  The Association Between METS-IR and Serum Ferritin Level in United States Female: A Cross-Sectional Study Based on NHANES.

Authors:  Han Hao; Yan Chen; Ji Xiaojuan; Zhang Siqi; Chu Hailiang; Sun Xiaoxing; Wang Qikai; Xing Mingquan; Feng Jiangzhou; Ge Hongfeng
Journal:  Front Med (Lausanne)       Date:  2022-06-28

3.  Intravenous iron is non-inferior to oral iron regarding cell growth and iron metabolism in colorectal cancer associated with iron-deficiency anaemia.

Authors:  Hafid O Al-Hassi; Oliver Ng; Rayko Evstatiev; Manel Mangalika; Natalie Worton; Manuela Jambrich; Vineeta Khare; Oliver Phipps; Barrie Keeler; Christoph Gasche; Austin G Acheson; Matthew J Brookes
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

4.  Increasing and decreasing phases of ferritin and hemosiderin iron determined by serum ferritin kinetics.

Authors:  Hiroshi Saito; Hisao Hayashi; Akihiro Tomita; Haruhiko Ohashi; Hideaki Maeda; Tomoki Naoe
Journal:  Nagoya J Med Sci       Date:  2013-08       Impact factor: 1.131

5.  Transformation rate between ferritin and hemosiderin assayed by serum ferritin kinetics in patients with normal iron stores and iron overload.

Authors:  Hiroshi Saito; Hisao Hayashi
Journal:  Nagoya J Med Sci       Date:  2015-11       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.